Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference50 articles.
1. Aroda VR, Ahmann A, Cariou B, et al. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 1–7 trials. Diabetes Metab. 2019;45(5):409–18.
2. NDA. National Diabetes Audit, 2017–18. Report 1: care processes and treatment targets. England and Wales. https://files.digital.nhs.uk/88/F1E544/National%20Diabetes%20Audit%202017-18%20Full%20Report%201%2C%20Care%20Processes%20and%20Treatment%20Targets.pdf. 2019. Accessed 18 Sept 2020.
3. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev. 2008;60(4):470–512.
4. Elrick H, Stimmler L, Hlad CJ Jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab. 1964;24:1076–82.
5. Creutzfeldt W. The incretin concept today. Diabetologia. 1979;16(2):75–85.
Cited by
152 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献